Dr. Maged Khalil, MD
Claim this profileLehigh Valley Health Network
Studies Solid Tumors
Studies Prostate Cancer
5 reported clinical trials
26 drugs studied
Area of expertise
1Solid Tumors
Stage III
MMR positive
MSI positive
2Prostate Cancer
Stage IV
Affiliated Hospitals
Clinical Trials Maged Khalil, MD is currently running
Targeted Therapy
for Advanced Stage Cancer
The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug. NOTE: Due to character limits, the arms section does NOT include all TAPUR Study relevant biomarkers. For additional information, contact TAPUR@asco.org, or if a patient, your nearest participating TAPUR site (see participating centers). \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\* Results in publication or poster presentation format are posted as they become available for individual cohorts at www.tapur.org/news. The results may be accessed at any time. All results will be made available on clinicaltrials.gov at the end of the study. Indexing of available results on PubMed is in progress. \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*
Recruiting1 award Phase 29 criteria
PD-1 Blockade + Chemoradiation
for Cancer
The purpose of this study is to find out whether the study drug, TSR-042, followed by standard chemoradiotherapy (the chemotherapy drug capecitabine + radiation therapy) and standard surgery is an effective treatment for advanced dMMR solid tumors. The study will also look at the safety of the study drug.
Recruiting1 award Phase 227 criteria
More about Maged Khalil, MD
Clinical Trial Related8 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Maged Khalil, MD has experience with
- Pembrolizumab
- Nivolumab
- TSR-042
- Enfortumab Vedotin
- Cabazitaxel
- Ipilimumab
Breakdown of trials Maged Khalil, MD has run
Solid Tumors
Prostate Cancer
Cancer
Rectal Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Maged Khalil, MD specialize in?
Is Maged Khalil, MD currently recruiting for clinical trials?
Are there any treatments that Maged Khalil, MD has studied deeply?
What is the best way to schedule an appointment with Maged Khalil, MD?
What is the office address of Maged Khalil, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.